CDK7 and renal cell carcinoma: Moreover, the effect of THZ1-induced CDK7 inhibition on RCC angiogenesis was further evaluated by determining the expression of CD31, an endothelial marker, through immunohistochemical staining (Figure 6B) and Western blot analysis (Figure 6C).